journal clubs | مرکز تحقیقات غدد و متابولیسم

ردیف	تاریخ ارائه	توضیحات
1	1405/3/21	سیتولوژی ندولهای تیروئید (AUS)
2	1405/04/18	Precision_Pituitary_Radiosurgery
3	1405/04/11	تشخیص بیماری کبد چرب و آشنایی با داروی Resmetirom
4	1405/02/31	کاربرد بالینی و مدیریت عوارض دارویی Tirzepatide
5	1405/02/24	hypercalcemia of malig
6	1405/02/17	Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
7	1404/7/3	2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
8	1404/2/18	The Porphyrias Disorders of Heme Synthesis
9	1404/2/11	Guideline for the Prevention and Treatment
10	1404/11/9	Case Presention
11	1404/11/30	Transition from childhood to adulthood in classic CAH
12	1404/11/23	درمان دارویی چاقی
13	1404/11/2	prolactinoma
14	1404/11/16	Revised European Society of Endocrinology Clinical Practice Guideline
15	1404/10/4	management of metabolic dysfunction-associated steatotic liver disease (MASLD)
16	1404/10/25	Finerinone from clinical needs to clinical application
17	1404/10/18	Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
18	1404/10/11	Standards of Care in Diabetes-2026
19	1404/1/28	HYPERTHYROHDISM
20	1404/1/21	Rdioactive Lodin Therapy
21	1404/09/27	Management of parathyroid disorders
22	1404/09/20	Evaluation and management of menopause and the perimenopause
23	1404/09/13	Sarcopenia in Patients with Type 2 Diabetes Mellitus
24	1404/08/29	European Society of Endocrinology and Endocrine Society Joint Clinical Guideline
25	1404/07/24	ATA-2025
26	1404/07/17	ATA Management Guidelines 2025 for Adult Patients with Differentiated Thyroid
27	1404/07/10	American Thyroid Association Management Guidelines 2025 for Adult Patients with Differentiated Thyroid Cancer
28	1403/12/9	Onset and progression of osteoporosis
29	1403/12/23	Diabetes insipidus
30	1403/12/2	screening or not screening T1D ISPAD 2024 Recommendations
31	1403/12/16	Ramadan and Diabetes
32	1403/11/25	Insulin Resistance and Diabetes Mellitus
33	1403/11/18	Adrenal cortical carcinoma
34	1403/11/11	Management of diabetic foot ulcers
35	1403/10/27	DIABETES AND CANCER
36	1403/10/20	Management of challenging and complicated patients with DM
37	1403/10/13	Dyslipidemia management in pregnant patients: a 2024 update
38	1403/10/06	Adrenal insufficiency:identification and management
39	1403/09/29	Pheochromocytoma and paraganglioma in children
40	1403/09/01	How to manage Cushing’s disease after failed primary pituitary surgery
41	1403/08/24	Surgical Approaches to the Adrenal Gland
42	1403/08/24	Surgery of the Adrenal Glands
43	1403/08/17	Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
44	1403/08/10	Acromegaly
45	1403/08/03	BEMPEDOIC ACID, DEVELOPMENT AND CLINICAL APPLICATION
46	1403/07/26	postmenopausal osteoporosis
47	1403/07/19	Salivary Cortisol test
48	1403/07/19	Late night salivary cortisol
49	1403/07/12	CKD-MBD
50	1403/07/05	Clinical Indication of FDG PET-CT in DTC
51	1403/04/14	The Genetic Testing in Endocrine Disorders
52	1403/03/31	Cyclic Cushing’s Disease
53	1403/03/20	Primary Aldosteronism Novel Approaches and Future Outlooks
54	1403/03/17	Diabetic Nephropathy
55	1403/03/10	GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
56	1403/03/03	2023 European Thyroid Association Clinical Practice Guidelines for Thyroid nodule management
57	1403/02/27	Bariatric Surgery
58	1403/02/13	Abnormal uterine bleeding in adolescents: Management
59	1403/02/06	Multimodality imaging of primary hyperparthyroidism
60	1403/01/30	Perioperative Evaluation and Management of Patients on Glucocorticoids
61	1403/01/16	Review of ICE 2024
62	1402/12/24	Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities
63	1402/12/17	Medical Nutrition Therapy IN Diabetes
64	1402/12/10	Diabetic Bladder or Diabetic Cystopathy &related complicationc
65	1402/12/03	The Revolution in Cholesterol Management: Putting REPATHA into practice
66	1402/11/26	EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
67	1402/11/12	Glucocorticoidinduced osteoporosis (GIOP)
68	1402/10/28	Thyroid Scintigraphy
69	1402/10/21	MTC
70	1402/10/14	Summary of Revisions: Standards of Medical Care in Diabetes—2024
71	1402/10/07	Summary of Revisions: Standards of Medical Care in Diabetes—2024
72	1402/09/30	OBESITY MANAGEMENT IN ADULTS
73	1402/09/23	Prolactinomas
74	1402/09/16	Updates on Thyroid eye disease
75	1402/09/09	Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
76	1402/08/25	Nuclear Medicine In Diabetic Foot
77	1402/08/18	Syndrome of Inappropriate Antidiuresis
78	1402/08/11	Hypothyroidism
79	1402/08/04	Management of Osteoporosis in Postmenopausal Woman
80	1402/07/27	EVALUATION & MANAGEMENT OF INFANT WITH DSD
81	1402/07/21	PCOS GUIDLINE 2023
82	1402/07/13	Adrenal Incidentaloma
83	1402/07/06	Acromegaly original
84	1401/08/10	Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
85	1400/04/04	A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
86	1400/03/28	Type 1 Diabetes: Management in Women From Preconception to Postpartum
87	1400/03/21	American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool
88	1400/03/07	Vitamin D Update
89	1400/02/31	Active Surveillance of Adult Low-Risk Papillary Thyroid Carcinoma
90	1400/02/17	Management of Hypertriglyceridemia
91	1400/02/10	Adrenal Incidentaloma
92	1400/02/03	Diagnosis and Treatment of NCCAH due to 21-Hydroxylase Deficiency
93	1400/01/27	New Oral Options for Diabetic Dyslipidemia Managment
94	1400/01/20	Testosterone Deficiency in Men
95	1399/12/22	The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
96	1399/12/15	Role of Nuclear Medicine in Endocrinology
97	1399/12/08	Pituitary Disorders in Pregnancy
98	1399/12/01	IDF DaR Guideline for people with diabetes who want to fast in Ramadan
99	1399/11/24	Thyroid Eye Disease: Managing a Condition with Grave Consequences
100	1399/11/17	Dyslipidemia in Children
101	1399/11/10	Clinical Indication of FDG PET-CT in DTC
102	1399/11/03	Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
103	1399/10/26	Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (NET)
104	1399/10/19	Lipid Management in Patients with Endocrine Disorders
105	1399/10/12	Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
106	1399/10/05	ADA 2021 Review
107	1399/09/28	Management of Graves‘ Thyroidal and Extrathyroidal Disease – An Update
108	1399/09/21	Approach to Managing a Postmenopausal Patient
109	1399/09/14	Endocrine Surgery during the Covid-19 pandemic
110	1399/09/07	Turner Syndrome Genome
111	1399/08/30	Glucocorticoid-Induced Osteoporosis
112	1399/08/09	Pituitary Incidentalomas
113	1399/08/02	How to use TBS in combination with BMD in clinical practice
114	1399/07/25	Glucocorticoid Induce Hyperglycemia
115	1399/07/18	Hypoparathyroidism
116	1399/07/11	Normocalcaemic Primary Hyerparathyroidism Normocalcaemic PHP
117	1399/07/04	GLP-1 AGONISTS vs SGLT2-inh ECE 2020
118	1399/03/27	PDE5 Inhibitors in Type 2 Diabetes Mellitus
119	1399/03/20	Dietary Fats and Health Outcome
120	1399/03/13	Medical Treatment with Somatostatin Analogues & Predictive Markers for Post-Surgical Medical Management of Acromegaly
121	1399/03/06	Pituitary-Tumor Endocrinopathies
122	1399/02/30	Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
123	1399/02/23	Osteoporosis in Men
124	1399/02/16	PCOS in Adolescents
125	1399/02/09	Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
126	1399/02/02	Diabetes & Ramadan Fasting - 2020
127	1399/01/26	COVID-19 and Endocrine System
128	1399/01/20	European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
129	1398/11/29	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
130	1398/11/15	Prolactinoma in Pregnancy and Menopause
131	1398/11/08	Nuclear Medicine & Parathyroid Diseases
132	1398/11/01	Management of Hypopituitarism
133	1398/10/24	Thermal Ablation for Papillary Thyroid Microcarcinomas
134	1398/10/17	ADA 2020 - Standards of Medical Care in diabetes
135	1398/10/10	2019European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
136	1398/10/03	Hypogonadism in Men
137	1398/09/26	Prolactinoma in Pregnancy
138	1398/09/19	Familial hypercholesterolemia in children “Diagnosis and Treatment “
139	1398/09/12	Contemporary Debates in Adult Papillary Thyroid Cancer Management
140	1398/09/05	Management Of Graves Orbitopathy
141	1398/08/28	Management of Difficult Osteoporosis
142	1398/08/21	Medical Management of Cushing’s Syndrome
143	1398/08/14	Prolactinoma
144	1398/07/30	Adrenal Crisis
145	1398/07/23	Drug Effects on the Thyroid
146	1398/07/16	Lipid
147	1398/07/09	Pheochromocytoma and Paraganglioma
148	1398/07/02	AROMATASE INHIBITORS AND BONE - ECE 2019
149	1398/03/28	Endocrine Treatment of Gender - Dysphoric/Transsexual Person
150	1398/03/21	Principles of DXA Scan Interpretation
151	1398/03/07	The Indeterminate Thyroid Nodule
152	1398/02/31	Prevention of Type 1 Diabetes
153	1398/02/24	Management of Medullary Thyroid Cancer
154	1398/02/17	Adrenal Imaging
155	1398/02/10	Osteoprosis Recumendations
156	1398/02/03	The Evaluation of Incidentally Discovered Adrenal Masses
157	1398/01/27	Update on Central Precocious Puberty: From Etiologies to Outcomes
158	1398/01/20	Treatment of Diabetes in Older Adults
159	1397/12/21	Diabetes Technology: Standards of Medical Care in Diabetes 2019
160	1397/12/14	The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
161	1397/12/07	Sglt2 Inhibitor
162	1397/11/30	Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
163	1397/11/23	BMD
164	1397/11/16	Thyroid and Pregnancy
165	1397/11/09	Long-term Safety & Efficacy of GH Treatment
166	1397/11/02	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
167	1397/10/25	The Diagnosis and Management of Nonalcoholic Fatty Liver Disease
168	1397/10/18	Gaps in Guidelines for the Management of Diabetes in Low and Middle-Income Versus High-Income Countries: A Systematic Review
169	1397/10/11	RAI in low risk DTC
170	1397/10/04	Management of Hyperglycemia in Type 2 Diabetes, 2018
171	1397/09/27	Diabetic Neuropathy
172	1397/09/20	OSTEOGENESIS IMPERFECTA
173	1397/09/13	Conventional & New Treatments of Hypoparathyroidism
174	1397/09/06	CONGENITAL ADRENAL HYPERPLASIA
175	1397/08/29	ORAL SEMAGLUTIDE vs PLACEBO
176	1397/08/15	ACROMEGALY
177	1397/08/01	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
178	1397/07/24	Adrenocortical Carcinoma
179	1397/07/17	Gestational Diabetes Underpinning Principles, Surveillance, and Management
180	1397/07/10	2018European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
181	1397/07/03	Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
182	1397/03/29	Charcot Foot
183	1397/03/22	X-linked Hypophosphatemic Rickets and its Treatment with Anti-FGF23
184	1397/03/08	Differentiated Thyroid Cancer Subtypes and Prognosis
185	1397/03/01	Incidence of Bone Metastases in Differentiated Thyroid Cancer
186	1397/02/25	Ramadan Fasting & Health
187	1397/02/18	Testosterone Therapy in Men With Hypogonadism
188	1397/02/11	Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
189	1397/01/28	Acromegaly: An Endocrine Society Clinical Practice Guideline
190	1397/01/21	European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
191	1397/01/14	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
192	1396/12/22	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Managment Algorithm-2018 Executive Summary
193	1396/12/15	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
194	1396/12/08	Some Points & Recommendations for Diagnosis Growth Hormone Deficiency in Children and Adolescents
195	1396/11/24	Definition of Pheochromocytomaand Paraganglioma (PPGL)
196	1396/11/17	Magnetic Resonance Imaging of Pituitary Tumors
197	1396/11/10	Diagnosis and Treatment PCOS
198	1396/11/03	Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
199	1396/10/26	KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, revention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
200	1396/10/19	Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents
201	1396/10/12	Clinically Nonfunctioning Pituitary Adenomas
202	1396/10/05	Standards of Medical Care in Diabetes - 2018
203	1396/09/28	AACE FOR MANAGEMENT OF DYSLIPIDEMIA
204	1396/09/14	Pituitary Apoplexy
205	1396/09/07	Non-Classic Congenital Adrenal Hyperplasia
206	1396/08/30	Nuclear Medicine in Neuroendocrine Tumors
207	1396/08/23	Type 2 Diabetes and Osteoporosis
208	1396/08/16	The Management of Primary Aldosteronism
209	1396/08/09	Prolactinoma
210	1396/08/02	PERIPHERAL PRECOCITY
211	1396/07/25	The follicular-variant papillary thyroid cancer (FVPTC)
212	1396/07/18	Gestational Diabetes Mellitus
213	1396/07/11	Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer - When to Use Systemic Therapy
214	1396/07/04	Management of Graves Orbitopathy ECE2017
215	1396/03/30	Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
216	1396/03/23	Pathogenesis and management of hypoglycemia
217	1396/03/16	Diabetes and Ramadan
218	1396/03/09	Combination Therapy in DM2
219	1396/03/02	Gastrointestinal Manifestations of Diabetes
220	1396/02/26	Ovarian Hyperthecosis
221	1396/02/19	Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
222	1396/02/12	An update on sodium-glucose co transporter-2 inhibitors for the treatment of diabetes mellitus
223	1396/01/15	Physiological and molecular responses to bariatric
224	1395/12/17	Physical activity and exercise in children with diabetes mellitus type 1
225	1395/12/10	Pseudohypoparathyroidism, Albright’s Hereditary Osteodystrophy-Disorders Caused by Inactivating GNAS Mutations
226	1395/11/26	Management of Osteoporosis
227	1395/11/19	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
228	1395/11/12	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
229	1395/11/07	Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly
230		Premature Ovarian Failure Clinical Presentation and Treatment
231		Clinical Practice Guidlines for the Diagnosis and Treatment of Postmenopausal Osteoprosis (2016)
232		Premature adrenarche
233		Diabetic Sensory and Motor Neuropathy
234		Update on subclinical thyroid dysfunction
235		Thyroid lymphoma
236		Glinids & Metformin
237		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis
238		Pharmacotherapy for obesity and type 2 diabetes
239		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 <span data-scayt_word="mL" data-scaytid="146">mL/min) - Dr.Karimifard
240		Postsurgical hypoparathyroidism definitions and management
241		Standards of Medical Care in Diabetes — 2016
242		Thiazolidinediones Alpha and Glucosidase Inhibitors
243		Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly: A Metaanalysis
244		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis part 2
245		Alcohol Ablation It’s indication, Efficacy, and Safety in Thyroid Disease
246		Central precocious puberty
247		Postoperative Management Following Pituitary Surgery
248		Diabetes and Ramadan: Practical Guidelines
249		The Increasing Incidence of Thyroid Cancer
250		EASD (2016)
251		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules
252		Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches
253		European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for phaeochromocytomaor a paraganglioma
254		Approach to diabetes mellitus in children and Adolescents
255		Postmenopausal Osteoporosis
256		Diagnostic tests of cushing syndrome
257		RED CELL TRANSFUSION
258		DPP-4 inhibitors
259		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
260		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
261		Limitation of current approaches for the treatment of acromegaly
262		COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM
263		Primary ovarian insufficiency (POI)
264		Comprehensive Type 2 Diabetes Managment Algorithm (part 2)
265		Primary Male Hypogonadism and Testosterone Therapy
266		Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
267		Timing of multiple endocrine neoplasia thyroidectomy and extent of central nacklymphadenectomy
268		Hyperglycemia Management In Patients With Post Transplantation Diabetes
269		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer